Latest Strategy Changes News

Red Metal Limited's March 2025 quarterly report reveals robust progress across its rare earth and base metals projects, underpinned by promising drilling results and supportive government funding.

Odyssey Gold Limited has made significant strides in its Tuckanarra Gold Project during the March 2025 quarter, completing a regional airborne electromagnetic survey and signing a joint venture Memorandum of Understanding for ore processing. The company also initiated a technical study and appointed Matthew Syme as Executive Director.

RLF AgTech has secured major national distribution agreements in Australia, launched a comprehensive retail rollout, and restructured its manufacturing arm, LiquaForce, to drive growth and operational efficiency. The company also reported strong financial performance and expanded its footprint across Asia.

Sunshine Metals reported a cash outflow for the March quarter driven by exploration activities but has bolstered its balance sheet with a $3 million placement, positioning itself for continued project development.

Sunshine Metals has made significant progress at its Ravenswood Consolidated Project with encouraging drilling results on shallow oxide gold targets and new gold-copper prospects, supported by a $3 million placement to fund further exploration.

Starpharma reports steady progress in its DEP® drug development programs, launches new marketing campaigns in key regions, and maintains a strong cash position of $17.2 million as it refines clinical strategies and partnerships.

Infinity Mining Limited reported a challenging quarter with net cash outflows from operations and investing, but bolstered its liquidity through a $1.87 million equity raise and plans to divest Western Australian projects.

Infinity Mining has expanded its exploration footprint with a new ~3,000 km² portfolio in Eastern Australia, identifying promising copper and gold targets while progressing divestment talks for its Western Australian assets.

Constellation Technologies Limited reports sustained sales growth and positive cash flow in Q3 2025, driven by its Callisto Food Safety & Compliance system and strategic market expansion.

Alterity Therapeutics reports compelling Phase 2 clinical trial results for ATH434 in Multiple System Atrophy, alongside a significant capital raise strengthening its financial position for upcoming regulatory milestones.

TG Metals Limited has secured an 80% stake in the Van Uden Gold Project in Western Australia, setting the stage for renewed exploration and resource evaluation. The company is poised to unlock near-term production potential through drilling and stockpile assessments.

Adherium Limited reports a surge in US commercial patients for its Hailie Smartinhaler platform, alongside strategic hires and a new product launch compatible with AstraZeneca inhalers, underpinning plans for a capital raise.